PSI-TEC Attracts Seasoned Lucent/Bell Labs Modulator Expert Dr. Gray D. Blake
|Industry Expert Will Guide Material Development Through Final Testing Phase; Company Developing EO Polymers for High-Speed Internet, Satellite and Military Applications|
“Drawing on his proven success with test requirements, equipment, procedures and practices, Dr. Blake will work closely with Dr. C.C. Teng, PSI-TEC's distinguished member of technical staff, to establish testing facilities for material evaluations”
PSI-TEC Corp., a wholly owned subsidiary of PSI-TEC Holdings Inc. (Pink Sheets:PTHO), a technology-based company developing chemical-based (polymer) materials for a wide roster of broadband telecommunication and military applications, announced today that it has engaged the consultancy services of former Lucent and Bell Labs veteran Dr. Gary D. Blake. PSI-TEC scientists and management expect Dr. Blake's extensive experience in modular technology to greatly accelerate the development and commercialization of PSI-TEC's breakthrough material designs.
PSI-TEC's molecularly-engineered materials are the basis of the company's revolutionary electro-optic technology product strategies. The resolution of the stability issue in material design, together with an exceptional R33 EO coefficient and high-yield material synthesis process, represents the potential to remove the final hurdle to the broad proliferation of low-cost EO polymers for numerous high-speed Internet, telecom, satellite and military applications.
"Dr. Blake's unique background and experience with modulator technology, together with his superb project management skills, is an ideal match for our emerging needs," stated Ron Genova, interim CEO of PSI-TEC Corp. "As it is imperative that we provide solid, credible performance data on our revolutionary nanotechnology-engineered EO polymer materials, we have reached the point where the collection and processing of test data must be performed using only the highest of industry-recognized practices and conditions. Dr. Blake's extensive expertise in this area will guide the project from testing to reporting and production in the coming months."
Dr. Blake's most recent accomplishments come from Lucent Technologies/Bell Labs where he supervised the design, fabrication, testing, qualification and production ramp of Lucent's highly successful lithium niobate modulator technology platform.
"Drawing on his proven success with test requirements, equipment, procedures and practices, Dr. Blake will work closely with Dr. C.C. Teng, PSI-TEC's distinguished member of technical staff, to establish testing facilities for material evaluations," said Frederick Goetz, Jr., president of PSI-TEC Corp. "The collaborative test facility effort by Dr. Blake and Dr. Teng is critical to confirming the soundness of our Aromatic Gain theory approach and will play an instrumental role in the future development and testing of waveguides, high-speed Mach-Zehnder modulators, and other devices created from our OE polymer material platform."
Company sources believe mu-beta and initial R33 EO coefficient test data (figures of merit for high-speed non-linear optic NLO polymer performance) could be released before the end of this year on the company's first commercial nanotechnology-engineered EO polymer molecule. The company projects definitive material stability testing will be completed shortly thereafter on waveguide structures.
PSI-TEC Corp. is a developmental stage company that engineers next-generation electro-optic (EO) plastics for future applications vital to modern commerce, homeland security and medical technology. PSI-TEC's proprietary electro-optic plastics are produced at the molecular level for superior performance, stability and cost-efficiency and are expected to replace more expensive, lower-performance materials used in fiber-optic ground, wireless and satellite communication networks. For more information regarding PSI-TEC's mission, management and technology, visit the company at www.psiteccorp.com.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the company's control.